GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK)
EBITDA Margin
26.51%
TTM · Period ending:
GSK EBITDA Margin
Latest reported26.51%period ending
Latest reported26.51%period ending
GSK TTM EBITDA Margin (44.20% → 26.51%)
TTM ebitda margin
High-resolution chart · PNG
GSK ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| 26.5111% | |
| 34.3859% | |
| 35.4813% | |
| 33.5852% | |
| 27.2296% | |
| 24.3934% | |
| 21.2519% | |
| 21.4174% | |
| 25.7171% | |
| 27.3357% | |
| 29.9492% | |
| 32.9688% | |
| 32.0172% | |
| 30.2043% | |
| 29.8456% | |
| 25.7328% | |
| 27.1773% | |
| 27.4635% | |
| 25.0846% | |
| 34.5364% | |
| 32.9591% | |
| 35.0295% | |
| 33.8338% | |
| 29.9051% | |
| 29.8422% | |
| 27.4484% | |
| 29.9259% | |
| 30.0466% | |
| 30.404% | |
| 26.8138% | |
| 24.0972% | |
| 18.5309% | |
| 19.201% | |
| 19.521% | |
| 20.4863% | |
| 23.1673% | |
| 20.2333% | |
| 17.9073% | |
| 15.8844% | |
| 12.2381% | |
| 11.4563% | |
| 15.0387% | |
| 53.8854% | |
| 57.4949% | |
| 57.9685% | |
| 60.8212% | |
| 22.4072% | |
| 27.7206% | |
| 31.6917% | |
| 32.3079% | |
| 33.2051% | |
| 34.4949% | |
| 33.0646% | |
| 33.0173% | |
| 33.2564% | |
| 31.4466% | |
| 33.5639% | |
| 34.3452% | |
| 36.2216% | |
| 27.9396% | |
| 27.6991% | |
| 21.1875% | |
| 19.9598% | |
| 29.0041% | |
| 29.1647% | |
| 35.7991% | |
| 36.0829% | |
| 34.3364% | |
| 33.8566% | |
| 34.7985% | |
| 35.8615% | |
| 38.0002% | |
| 31.2112% | |
| 31.1736% | |
| 32.0017% | |
| 29.7408% | |
| 38.0901% | |
| 37.8466% | |
| 37.0241% | |
| 9.5829% | |
| 8.4059% | |
| 7.339% | |
| 5.308% | |
| 32.7413% | |
| 32.1467% | |
| 32.6262% | |
| 32.4889% | |
| 33.9482% | |
| 34.3202% | |
| 34.2995% | |
| 33.8224% | |
| 35.2676% | |
| 32.7429% | |
| 31.2717% | |
| 30.8127% | |
| 37.9015% | |
| 35.8594% | |
| 35.5245% | |
| 33.6808% | |
| 32.8359% |